The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Gut microbiota and metabolic syndrome
Open accessAbstract
Gut microbiota exerts a significant role in the pathogenesis of the metabolic syndrome, as confirmed by studies conducted both on humans and animal models. Gut microbial composition and functions are strongly influenced by diet. This complex intestinal "superorganism" seems to affect host metabolic balance modulating energy absorption, gut motility, appetite, glucose and lipid metabolism, as well as hepatic fatty storage. An impairment of the fine balance between gut microbes and host's immune system could culminate in the intestinal translocation of bacterial fragments and the development of "metabolic endotoxemia", leading to systemic inflammation and insulin resistance. Diet induced weight-loss and bariatric surgery promote significant changes of gut microbial composition, that seem to affect the success, or the inefficacy, of treatment strategies. Manipulation of gut microbiota through the administration of prebiotics or probiotics could reduce intestinal low grade inflammation and improve gut barrier integrity, thus, ameliorating metabolic balance and promoting weight loss. However, further evidence is needed to better understand their clinical impact and therapeutic use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the effects of probiotic and prebiotic supplementation on metabolic health have been examined in previous studies, the results are inconsistent due to the choice of probiotic strain, formulation of the probiotic, outcome of interest, and duration of the intervention [12,13,14].”
From Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study (2019) · cites this paper as [12]
In the citing paper
“Alterations in gut microbiota diversity, composition, and function were suggested to play a significant role in the development of MetS [12].”
From Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study (2019) · cites this paper as [12]
Citations
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedInternational Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,379
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Cited by
Sorted by citations
The Controversial Role of Human Gut Lachnospiraceae
Vacca, M., Celano, G., Calabrese, F. M., Portincasa, P., Gobbetti, M., & De Angelis, M. (2020) · Microorganisms · doi:10.3390/microorganisms8040573 · Cited by 1,688
Koliada, A., Syzenko, G., Moseiko, V., Budovska, L., Puchkov, K., Perederiy, V., Gavalko, Y., Dorofeyev, A., Romanenko, M., Tkach, S., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1027-1 · Cited by 1,000
Mechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
Mechanisms of Oxidative Stress in Metabolic Syndrome
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097898 · Cited by 816
Michielan, A., & D’Incà, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/628157 · Cited by 709
Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes
Kolb, H., & Martin, S. (2017) · BMC Medicine · doi:10.1186/s12916-017-0901-x · Cited by 794
Lane, M. M., Davis, J. A., Beattie, S., Gómez‐Donoso, C., Loughman, A., O'Neil, A., Jacka, F., Berk, M., Page, R., Marx, W., et al. (2021) · Obesity Reviews · doi:10.1111/obr.13146 · Cited by 564
Gut Microbiota and Obesity: A Role for Probiotics
Abenavoli, L., Scarpellini, E., Colica, C., Boccuto, L., Salehi, B., Sharifi-Rad, J., Aiello, V., Romano, B., De Lorenzo, A., Izzo, A. A., et al. (2019) · Nutrients · doi:10.3390/nu11112690 · Cited by 615
Liu, B., Liu, X., Liang, Z., & Wang, J. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i25.3837 · Cited by 662
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
Cuevas-Sierra, A., Ramos-Lopez, O., Riezu-Boj, J. I., Milagro, F. I., & Martinez, J. A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy078 · Cited by 523
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487
Probiotic supplements might not be universally-effective and safe: A review
Kothari, D., Patel, S., & Kim, S.-K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.104 · Cited by 445
Influence of gut microbiota on neuropsychiatric disorders
Cénit, M. C., Sanz, Y., & Codoñer‐Franch, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i30.5486 · Cited by 433
Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice
Fransen, F., van Beek, A. A., Borghuis, T., Aidy, S. E., Hugenholtz, F., van der Gaast – de Jongh, C., Savelkoul, H. F. J., De Jonge, M. I., Boekschoten, M. V., Smidt, H., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01385 · Cited by 403
Insulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 434
Probiotics, prebiotics and amelioration of diseases
Tsai, Y.-L., Lin, T.-L., Chang, C.-J., Wu, T.-R., Lai, W.-F., Lu, C.-C., & Lai, H.-C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-018-0493-6 · Cited by 388
The dormant blood microbiome in chronic, inflammatory diseases
Potgieter, M., Bester, J., Kell, D. B., & Pretorius, E. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv013 · Cited by 384
Gut microbiota markers associated with obesity and overweight in Italian adults
Palmas, V., Pisanu, S., Madau, V., Casula, E., Deledda, A., Cusano, R., Uva, P., Vascellari, S., Loviselli, A., Manzin, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84928-w · Cited by 385
Kaliannan, K., Wang, B., Li, X., Kim, K., & Kang, J. X. (2015) · Scientific Reports · doi:10.1038/srep11276 · Cited by 375
Rao, Y., Kuang, Z., Li, C., Guo, S., Xu, Y., Zhao, D., Hu, Y., Song, B., Jiang, Z., Ge, Z., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1927633 · Cited by 356
Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals
Sedighi, M., Razavi, S., Navab-Moghadam, F., Khamseh, M. E., Alaei-Shahmiri, F., Mehrtash, A., & Amirmozafari, N. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.08.038 · Cited by 306
Antibiotic use and microbiome function
Ferrer, M., Méndez–García, C., Rojo, D., Barbas, C., & Moyá, A. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.007 · Cited by 315
Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control
Próchnicki, T., & Latz, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.018 · Cited by 302
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Bovi, A. P. D., Marciano, F., Mandato, C., Siano, M., Savoia, M., & Vajro, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.595371 · Cited by 318
Nonalcoholic Fatty Liver Disease
Carr, R. M., Oranu, A. C., & Khungar, V. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.07.003 · Cited by 289
Kang, Y., Kang, X., Yang, H., Liu, H., Yang, X., Liu, Q., Tian, H., Xue, Y., Ren, P., Kuang, X., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106020 · Cited by 288
Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota
Wei, X., Tao, J., Xiao, S., Jiang, S., Shang, E., Zhu, Z., Qian, D., & Duan, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22094-2 · Cited by 257
Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates
Montalban‐Arques, A., Schryver, P. D., Bossier, P., Gorkiewicz, G., Mulero, V., Gatlin, D. M., & Galindo‐Villegas, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00512 · Cited by 224
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
Lazăr, V., Diţu, L.-M., Pîrcălăbioru, G. G., Picu, A. A., Petcu, L. M., Cucu, N., & Chifiriuc, M. C. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00021 · Cited by 211
Wang, S., Yu, Y., & Adeli, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040527 · Cited by 216
Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
Ma, J., Zhou, Q., & Li, H. (2017) · Nutrients · doi:10.3390/nu9101124 · Cited by 197
Luca, M., Di Mauro, M., Di Mauro, M., & Luca, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4730539 · Cited by 190
Gut-Microbiota-Metabolite Axis in Early Renal Function Decline
Barrios, C., Beaumont, M., Pallister, T., Villar, J., Goodrich, J. K., Clark, A., Pascual, J., Ley, R. E., Spector, T. D., Bell, J. T., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134311 · Cited by 175
High dietary salt–induced DC activation underlies microbial dysbiosis-associated hypertension
Ferguson, J. F., Aden, L. A., Barbaro, N. R., Beusecum, J. P. V., Xiao, L., Simmons, A. J., Warden, C., Pasic, L., Himmel, L. E., Washington, M. K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126241 · Cited by 186
The Role of the Gut Microbiota in the Pathogenesis of Diabetes
Bielka, W., Przezak, A., & Pawlik, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010480 · Cited by 189
Talking microbes: When gut bacteria interact with diet and host organs
Cani, P. D., & Everard, A. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500406 · Cited by 181
Bisphenol A alters gut microbiome: Comparative metagenomics analysis
Lai, K.-P., Chung, Y.-T., Li, R., Wan, H.-T., & Wong, C. K.-C. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.08.039 · Cited by 175
Gut Microbiota and Celiac Disease
Marasco, G., Biase, A. R. D., Schiumerini, R., Eusebi, L. H., Iughetti, L., Ravaioli, F., Scaioli, E., Colecchia, A., & Festi, D. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-4020-2 · Cited by 176
Self-citationPlant Prebiotics and Their Role in the Amelioration of Diseases
Kaur, A. P., Bhardwaj, S., Dhanjal, D. S., Nepovimová, E., Martins, N. A., Kuča, K., Chopra, C., Singh, R., Kumar, H., Şen, F., et al. (2021) · Biomolecules · doi:10.3390/biom11030440 · Cited by 174
Aron, R. A. C., Abid, A., Vesa, C. M., Nechifor, A. C., Behl, T., Ghitea, T. C., Munteanu, M. A., Frățilă, O., Andronie-Cioară, F. L., Toma, M. M., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9030618 · Cited by 174
Probiotics for people with hepatic encephalopathy
Dalal, R., McGee, R., Riordan, S. M., & Webster, A. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008716.pub3 · Cited by 175
Reynolds, A. C., Paterson, J. L., Ferguson, S. A., Stanley, D., Wright, K. P., & Dawson, D. E. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.06.009 · Cited by 173
The Intestinal Lymphatic System: Functions and Metabolic Implications
Cifarelli, V., & Eichmann, A. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.12.002 · Cited by 157
Sfanos, K. S., Markowski, M. C., Peiffer, L. B., Ernst, S. E., White, J. R., Pienta, K. J., Antonarakis, E. S., & Ross, A. E. (2018) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-018-0061-x · Cited by 151
Lactoferrin, a Pleiotropic Protein in Health and Disease
Mayeur, S., Spahis, S., Pouliot, Y., & Levy, E. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6458 · Cited by 145
BELLIKCI-KOYU, E., SARER-YUREKLI, B. P., AKYON, Y., AYDIN-KOSE, F., KARAGOZLU, C., OZGEN, A. G., BRINKMANN, A., NITSCHE, A., ERGUNAY, K., YILMAZ, E., et al. (2019) · Nutrients · doi:10.3390/nu11092089 · Cited by 144
“Alterations in gut microbiota diversity, composition, and function were suggested to play a significant role in the development of MetS [12].”
BackgroundThe endocrinology of taste receptors
Calvo, S. S.-C., & Egan, J. M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.7 · Cited by 148
Bray, M. S., Loos, R. J. F., McCaffery, J. M., Ling, C., Franks, P. W., Weinstock, G. M., Snyder, M. P., Vassy, J. L., Agurs‐Collins, T., & The Conference Working Group (2016) · Obesity · doi:10.1002/oby.21381 · Cited by 138
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease
Basson, A. R., Trotter, A., Rodriguez‐Palacios, A., & Cominelli, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00290 · Cited by 140
Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome
Bridgeman, S. C., Northrop, W., Melton, P. E., Ellison, G., Newsholme, P., & Mamotte, C. D. S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105174 · Cited by 137
Phytosterols: Nutritional Health Players in the Management of Obesity and Its Related Disorders
Vezza, T., Canet, F., Marañón, A., Bañuls, C., Rocha, M., & Víctor, V. M. (2020) · Antioxidants · doi:10.3390/antiox9121266 · Cited by 136
Microbiome and diabetes: Where are we now?
Vallianou, N. G., Stratigou, T., & Tsagarakis, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.008 · Cited by 126
Exploring the gut microbiota: lifestyle choices, disease associations, and personal genomics
Matute, S. P., & Iyavoo, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1225120 · Cited by 143
Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans
Chassaing, B., Raja, S. M., Lewis, J. D., Srinivasan, S., & Gewirtz, A. T. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.04.001 · Cited by 130
Grosicki, G. J., Riemann, B. L., Flatt, A. A., Valentino, T. R., & Lustgarten, M. S. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.04.013 · Cited by 125
Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems
Mulders, R. J., de Git, K. C. G., Schéle, E., Dickson, S. L., Sanz, Y., & Adan, R. A. H. (2018) · Obesity Reviews · doi:10.1111/obr.12661 · Cited by 120
Gao, X., Xie, Q., Kong, P., Liu, L., Sun, S., Xiong, B., Huang, B., Yan, L., Sheng, J., & Xiang, H. (2017) · Infection and Immunity · doi:10.1128/iai.00601-17 · Cited by 120
Thiennimitr, P., Yasom, S., Tunapong, W., Chunchai, T., Wanchai, K., Pongchaidecha, A., Lungkaphin, A., Sirilun, S., Chaiyasut, C., Chattipakorn, N., et al. (2018) · Nutrition · doi:10.1016/j.nut.2018.03.005 · Cited by 118
Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis
Luna‐Luna, M., Medina-Urrutia, A. X., Vargas‐Alarcón, G., Coss-Rovirosa, F., Vargas‐Barrón, J., & Pérez-Méndez, O. A. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.007 · Cited by 111
Dietary fiber intake and risk of metabolic syndrome: A meta-analysis of observational studies
Wei, B., Liu, Y., Lin, X., Fang, Y., Cui, J., & Wan, J. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.10.019 · Cited by 112
Metabolically Healthy Obesity—Heterogeneity in Definitions and Unconventional Factors
Brandão, I., Martins, M. J., & Monteiro, R. (2020) · Metabolites · doi:10.3390/metabo10020048 · Cited by 117
Exploratory metabolomics of metabolic syndrome: A status report
Lent-Schochet, D., McLaughlin, M. J., Ramakrishnan, N., & Jialal, I. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i1.23 · Cited by 108
Gut microbiota in cardiovascular disease and heart failure
Kitai, T., & Tang, W. H. W. (2018) · Clinical Science · doi:10.1042/cs20171090 · Cited by 106
Kassaian, N., Feizi, A., Aminorroaya, A., Jafari, P., Ebrahimi, M. T., & Amini, M. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1175-2 · Cited by 100
Oxidative stress in metabolic diseases: current scenario and therapeutic relevance
Raut, S. K., & Khullar, M. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04496-z · Cited by 100
Askari, G., Asgharian, A., Esmailzade, A., Feizi, A., & Mohammadi, V. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.178533 · Cited by 102
Luo, D., Chen, K., Li, J., Fang, Z., Pang, H., Yin, Y., Rong, X., & Guo, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109550 · Cited by 102
Molina‐Tijeras, J. A., Diez‐Echave, P., Vezza, T., Hidalgo‐Garcia, L., Ruiz‐Malagón, A. J., Rodríguez‐Sojo, M. J., Romero, M., Robles‐Vera, I., García, F., Plaza‐Díaz, J., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105471 · Cited by 100
Lin, S., Wang, Z., Lam, K., Zeng, S., Tan, B. K., & Hu, J. (2019) · Food & Nutrition Research · doi:10.29219/fnr.v63.1518 · Cited by 96
Wang, S., Li, Q., Zang, Y., Zhao, Y., Liu, N., Wang, Y., Xu, X., Liu, L., & Mei, Q. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.02.074 · Cited by 97
Endocrine causes of nonalcoholic fatty liver disease
Marino, L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.11053 · Cited by 93
Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Thacker, L. R., Daita, K., Kang, D. J., White, M. B., Unser, A. B., Fagan, A., Gavis, E. A., et al. (2015) · Scientific Reports · doi:10.1038/srep18559 · Cited by 92
Microbiome-Driven Therapeutics: From Gut Health to Precision Medicine
Yaqub, M. O., Jain, A., Joseph, C. E., & Edison, L. K. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7010007 · Cited by 100
Antibiotics, gut microbiome and obesity
Leong, K. S. W., Derraik, J. G. B., Hofman, P. L., & Cutfield, W. S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13495 · Cited by 98
Microbial Population Changes and Their Relationship with Human Health and Disease
Álvarez‐Mercado, A. I., Navarro-Oliveros, M., Robles-Sánchez, C., Plaza‐Díaz, J., Sáez‐Lara, M. J., Muñoz‐Quezada, S., Fontana, L., & Abadía‐Molina, F. (2019) · Microorganisms · doi:10.3390/microorganisms7030068 · Cited by 93
The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy
Assumpção, J. A. F., Pasquarelli-do-Nascimento, G., Viegas, M. S., Bonamino, M., & Magalhães, K. G. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00796-0 · Cited by 97
Human Gut Microbiota in Health and Alzheimer’s Disease
Szablewski, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170908 · Cited by 96
Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy
Mancini, A., Campagna, F., Amodio, P., & Tuohy, K. M. (2018) · Food & Function · doi:10.1039/c7fo01528c · Cited by 89
García–Peñarrubia, P., Ruiz‐Alcaraz, A. J., Martinez‐Esparza, M., Marín‐Sánchez, P., & Machado‐Linde, F. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz044 · Cited by 89
Disparate effects of antibiotics on hypertension
Galla, S., Chakraborty, S., Cheng, X., Yeo, J., Mell, B., Zhang, H. Y., Mathew, A. V., Vijay–Kumar, M., & Joe, B. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00073.2018 · Cited by 85
The Gut Microbiome, Inflammation, and Salt-Sensitive Hypertension
Elijovich, F., Laffer, C. L., Sahinoz, M., Pitzer, A. L., Ferguson, J. F., & Kirabo, A. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01091-9 · Cited by 90
Zhang, F., Qiu, L., Xu, X., Liu, Z., Zhan, H., Tao, X., Shah, N. P., & Wei, H. (2016) · Journal of Dairy Science · doi:10.3168/jds.2016-11870 · Cited by 85
Microbiota manipulation for weight change
Dror, T., Dickstein, Y., Dubourg, G., & Paul, M. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.01.002 · Cited by 82
Role of the inflammasome in insulin resistance and type 2 diabetes mellitus
Lu, S., Li, Y., Qian, Z., Zhao, T., Feng, Z., Weng, X., & Yu, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1052756 · Cited by 91
Microbiota in Gut‐Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease
Kondapalli, N. B., Katari, V., Dalal, K. K., Paruchuri, S. M., & Thodeti, C. K. (2025) · Comprehensive physiology · doi:10.1002/cph4.70024 · Cited by 98
Dong, Y., Xu, M., Chen, L., & Bhochhibhoya, A. (2019) · Annals of Nutrition and Metabolism · doi:10.1159/000499028 · Cited by 85
Akt: A Potential Drug Target for Metabolic Syndrome
Miao, R., Fang, X., Wei, J., Wu, H., Wang, X., & Tian, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.822333 · Cited by 90
Zhang, B., Chen, T., Cao, M., Yuan, C., Reiter, R. J., Zhao, Z., Zhao, Y., Chen, L., Fan, W., Wang, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900132 · Cited by 80
Goñi, L., Cuervo, M., Milagro, F. I., & Martínez, J. A. (2016) · Journal of Nutrition · doi:10.3945/jn.115.218354 · Cited by 81
Kassaian, N., Feizi, A., Aminorroaya, A., & Amini, M. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.07.016 · Cited by 78
Microbiota: a novel regulator of pain
Defaye, M., Gervason, S., Altier, C., Berthon, J., Ardid, D., Filaire, E., & Carvalho, F. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02083-z · Cited by 81
Niu, C., Hu, X.-L., Yuan, Z., Xiao, Y., Ji, P., Wei, Y., & Hua, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115741 · Cited by 78
Hamjane, N., Mechita, M. B., Nourouti, N. G., & Barakat, A. (2023) · Microvascular Research · doi:10.1016/j.mvr.2023.104601 · Cited by 92
Small Intestinal Bacterial Overgrowth Is Associated with Non- Alcoholic Fatty Liver Disease
Fialho, A. B. C., Fialho, A., Thota, P. N., McCullough, A. J., & Shen, B. (2016) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.252.iwg · Cited by 76
Qu, Q., Fang, Y., Zhao, C., Liu, X., Yang, P., Li, Z., Han, L., & Shi, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113594 · Cited by 75
The Metabolic Syndrome, a Human Disease
Alemany, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042251 · Cited by 86
Singhal, M., Turturice, B. A., Manzella, C. R., Ranjan, R., Metwally, A. A., Theorell, J. A., Huang, Y. L., Alrefai, W. A., Dudeja, P. K., Finn, P. W., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38489-8 · Cited by 75
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Wang, H., Zhang, H., Gao, Z., Zhang, Q., & Gu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854885 · Cited by 69
“Numerous studies have shown that alterations in the composition of the gut microbiota have been associated with metabolic disorders (Festi et al., 2014; Ussar et al., 2015), including obesity (Gomes et al.”
BackgroundRegulatory effect of paraprobioticLactobacillus gasseriCP2305 on gut environment and function
Sugawara, T., Sawada, D., Ishida, Y., Aihara, K., Aoki, Y., Takehara, I., Takano, K., & Fujiwara, S. (2016) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v27.30259 · Cited by 70
Metadata
- Authors
- Festi, D., Schiumerini, R., Eusebi, L. H., Marasco, G., Taddia, M., & Colecchia, A.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- ORCID
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 43
- Pages
- 16079
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC4239493
- OpenAlex
- W2754567481
- Cited by
- 534
- References
- 138
- Citations by year
- 2026: 16 · 2025: 43 · 2024: 39 · 2023: 42 · 2022: 74 · 2021: 71 · 2020: 54 · 2019: 46 · 2018: 41 · 2017: 43 · 2016: 37 · 2015: 28
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by-nc)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, metabolic syndrome, diet, energy absorption, intestinal motility, appetite regulation, glucose metabolism, lipid metabolism, bacterial translocation, metabolic endotoxemia, systemic inflammation, insulin resistance, bariatric surgery, weight loss, prebiotics, probiotics, intestinal barrier integrity
- MeSH terms
- Animals, Diet, Energy Metabolism, Humans, Intestinal Mucosa, Intestines, Obesity, Weight Loss, Treatment Outcome, Bacterial Translocation, Probiotics, Metabolic Syndrome, Caloric Restriction, Bariatric Surgery, Host-Pathogen Interactions, Prebiotics, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review